Abstract:The periostin protein, encoded by the POSTN gene, is a component of the extracellular matrix, which is expressed by fibroblasts and has been observed in a variety of human malignancies. The present study aimed to detect the expression of periostin in the tissues of non-small cell lung cancer (NSCLC) patients and benign lung tumors, and to correlate the results with the clinicopathological data of the subjects, in order to evaluate periostin as a potential prognostic marker. In total, 49 NSCLC patients and 6 benign lung tumors were included in this study. The protein level of periostin was detected in paired normal/paratumor/cancer tissues by a western blot analysis and the mRNA level in paired normal/cancer tissues was detected by quantitative polymerase chain reaction (qPCR). The results were then correlated with established biological and prognostic factors. Immunohistochemistry was used to confirm the location of periostin in the NSCLC tissues. Uni- and multivariate analyses were performed using Cox's proportional hazards regression model. The protein level of periostin was elevated in the cancer tissue of the NSCLC patients compared with the normal (P=0.017) and paratumor (P=0.000) tissues. The expression level in the male patients was much higher than in the female patients at the protein (P=0.001) and mRNA (P=0.010) levels. The mRNA level in the non-adenocarcinoma (non-ADC) patients was much higher than in the adenocarcinoma (ADC) patients (P=0.029). Periostin was demonstrated higher expression at the protein level in the pseudotumors and tuberculosis patients than in the adjacent (P=0.016) and surrounding tissues (P=0.001). Immunostaining indicated that high levels of periostin were present in the mesenchymal areas, but not in the cancer cells themselves. The patients with tumors exhibiting high-level periostin expression showed a significantly shorter survival time (P=0.036, log-rank test). The 3-year survival rate was 81.5% for patients with low-level periostin expression (periostin-L; n=27) and 45.4% for patients with high-level periostin expression (periostin-H; n=22). Similarly, pathological node (pN) status was a significant prognostic marker in the univariate Cox survival analysis. Notably, periostin-H expression was also identified as an independent prognostic factor by the multivariate analysis (P=0.011). These results showed that the overexpression of periostin predicts a poor prognosis, therefore it may be regarded as a novel molecule in the progression and development of NSCLC. The results provide an additional target for the adjuvant treatment of NSCLC.

Pathological Roles and Clinical Usefulness of Periostin in Type 2 Inflammation and Pulmonary Fibrosis

Periostin: An emerging biomarker for allergic diseases

Periostin: Its Role in Asthma and Its Potential As a Diagnostic or Therapeutic Target

Roles of periostin in cancer

Serum periostin is a potential biomarker for non-alcoholic fatty liver disease: a case–control study

The Role of Periostin in Tissue Remodeling Across Health and Disease.

Serum periostin does not reflect type 2-driven inflammation in COPD

Potential Value of Periostin as a Clinically Applicable Biomarker for Osteoarthritis

Periostin secreted by activated fibroblasts in idiopathic pulmonary fibrosis promotes tumorigenesis of non-small cell lung cancer

The role of biomarkers in the diagnosis and treatment follow-up of idiopathic pulmonary fibrosis

Periostin A Potential Therapeutic Target For Pulmonary Hypertension?

Predictive and Prognostic Value of Serum Periostin in Advanced Non–small Cell Lung Cancer Patients Receiving Chemotherapy

Biomarkers and their potential functions in idiopathic pulmonary fibrosis

The research status and prospect of Periostin in chronic kidney disease

Increased Periostin Expression Affects the Proliferation, Collagen Synthesis, Migration and Invasion of Keloid Fibroblasts under Hypoxic Conditions.

A pilot HRCT follow-up study to test the feasibility of predictive efficacy of serum periostin in idiopathic pulmonary fibrosis

Periostin in Chronic Liver Diseases: Current Research and Future Perspectives

Periostin: novel tissue and urinary biomarker of progressive renal injury induces a coordinated mesenchymal phenotype in tubular cells

Overexpression of Periostin Predicts Poor Prognosis in Non-Small Cell Lung Cancer.

Periostin, a Multifunctional Matricellular Protein in Inflammatory and Tumor Microenvironments

Research progress of periostin and osteoporosis